$TDOC

Rodrigues Fernando M. sold $71K of TDOC

Rodrigues Fernando M. (President of BetterHelp) sold 9,572 shares of Teladoc Health, Inc. (TDOC) at $7.40 on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Rodrigues Fernando M.
Published Jun 4, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TDOC
Neutral
medium confidence
Mentioned
$TDOC
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TDOCNeutralLow
01

Why it matters

The disclosure provides a datapoint on insider activity but does not introduce new company fundamentals; interpretive value is reduced by the stated pre-arranged 10b5-1 plan.

02

Market read

Traders may briefly reassess sentiment/positioning around TDOC due to disclosed insider selling, but the scheduled nature limits conviction.

03

What to watch

Insider selling volume alone is not a reliable predictor; traders should compare with prior Form 4 patterns and any concurrent company-specific news (earnings, guidance, litigation).

Relevance 6/10Novelty 3/10Timing: Filed after-hours (2026-06-04 16:05 ET) for a sale executed 2026-06-03

Background

This is an SEC Form 4 insider transaction disclosure for Teladoc Health, Inc. (TDOC).

Company-level read

Ticker impact

$TDOCNeutralMedium confidence
Context

SEC Form 4 shows TDOC officer Rodrigues Fernando M. sold 9,572 shares in an open-market transaction under a 10b5-1 plan.

Expected impact

Small, short-lived negative bias possible; no clear directional catalyst beyond disclosure.

Evidence & confidence

The filing is a routine insider transaction and explicitly tied to a pre-arranged 10b5-1 plan, reducing interpretive value versus discretionary selling.

Market effects

Minimal; single-company insider sale with no sector-wide catalyst.

None.

None.

Counterpoint

Because the sale is under a 10b5-1 plan and the position is fully exited, it may reflect scheduled liquidity rather than bearish expectations.

Key entities

  • Teladoc Health, Inc.

    Subject of the Form 4 insider transaction; officer sold shares under a 10b5-1 plan.

  • Rodrigues Fernando M.

    President of BetterHelp; reported as an officer of the issuer for Form 4 purposes.

Related articles

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky

Levi & Korsinsky said it is investigating Teladoc Health (NYSE: TDOC) after the company reported Q2 2026 revenue of $606.9 million, below consensus of $615 million to $628 million, and cut full-year 2026 revenue guidance to $2.36 billion to $2.45 billion. The notice cites prior guidance changes and comments about BetterHelp cash pay user declines and insurance capacity.

$METAMed

Futures Rise As Oil Drops, Bond Selling Slows, Meta Tumbles And Microsoft Soars

US stock index futures rose in premarket after a prior selloff tied to Fed-related concerns. Microsoft shares jumped about 9% after cloud growth accelerated, while Meta fell about 8% after revenue guidance disappointed and free cash flow was weak. Bond selling slowed and 30-year yields hit a two-decade high near 5.22%. Several other earnings moves were reported, including MO, CVNA, CMG, and QCOM.